First In Human Phase 1 Study of INCAGN02385, a LAG-3 Monoclonal Antibody Antagonist in Patients With Advanced Malignancies
INCAGN-02385
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: First In Human Phase 1 Study of INCAGN02385, a LAG-3 Monoclonal Antibody Antagonist in Patients With Advanced Malignancies ### Output: INCAGN-02385